Prognostic value of CT-measured baseline tumor volume in nivolumab-treated metastatic renal cell carcinoma. (PubMed, Tumori) - Oct 9, 2026 - "Higher baseline metastatic tumor volume was associated with poorer survival outcomes in patients with mRCC treated with nivolumab. CT-based tumor volumetry may provide complementary prognostic information; however, these exploratory findings require validation in larger, prospective cohorts."
Journal • Genito-urinary Cancer • Oncology • Renal Cell Carcinoma • Solid Tumor
|
|
Caner Kapar; Deniz Tural; Maide Müreva; Mustafa Orhan Nalbant; Rumeysa Colak
|